Genenta Financial Statements From 2010 to 2026

GNTA Stock  USD 0.88  0.04  4.35%   
Genenta Science's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Genenta Science's valuation are provided below:
Market Capitalization
21.6 M
Earnings Share
(0.56)
We have found one hundred twenty available fundamental trends for Genenta Science SpA, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Genenta Science SpA regular market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 140.9 M. The current year's Enterprise Value is expected to grow to about 120.5 M
Check Genenta Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genenta Science's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 73 K or Depreciation And Amortization of 38.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.94. Genenta financial statements analysis is a perfect complement when working with Genenta Science Valuation or Volatility modules.
  
Build AI portfolio with Genenta Stock
Check out the analysis of Genenta Science Correlation against competitors.

Genenta Science Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets19.9 M13.3 M22.1 M
Very volatile
Other Current Liabilities1.2 M1.6 M1.7 M
Slightly volatile
Total Current Liabilities1.6 M1.9 M2.2 M
Slightly volatile
Total Stockholder Equity18.3 M11.2 M19.8 M
Very volatile
Other Liabilities140.3 K133.6 K51.1 K
Slightly volatile
Net Tangible Assets13.6 M13.6 M17.1 M
Slightly volatile
Accounts Payable416.6 K286 K528.2 K
Slightly volatile
Cash3.9 M4.1 M17.7 M
Slightly volatile
Non Current Assets Total300.1 K315.9 K793.9 K
Very volatile
Non Currrent Assets Other188.4 K198.3 K757.2 K
Pretty Stable
Cash And Short Term Investments17.9 M11.4 M20.3 M
Pretty Stable
Net Receivables1.4 M1.7 M856.2 K
Slightly volatile
Common Stock Shares Outstanding20 M21 M18.4 M
Slightly volatile
Liabilities And Stockholders Equity19.9 M13.3 M22.1 M
Very volatile
Non Current Liabilities Total276.4 K263.3 K72.1 K
Slightly volatile
Other Current Assets366.1 K328.3 K531.5 K
Slightly volatile
Total Liabilities1.7 M2.1 M2.3 M
Slightly volatile
Net Invested Capital18.3 M11.2 M19.8 M
Very volatile
Total Current Assets19.1 M13 M21.2 M
Very volatile
Capital Stock49.2 M78.7 M23.3 M
Slightly volatile
Net Working Capital17.5 M11.1 M19 M
Very volatile
Common Stock49.2 M78.7 M23.3 M
Slightly volatile
Property Plant And Equipment Gross99.6 K162.4 K54.3 K
Slightly volatile
Property Plant Equipment15.2 K17.1 K18.6 K
Slightly volatile
Non Current Liabilities Other990K21.9 K
Slightly volatile
Intangible Assets51.7 K101 K17.3 K
Slightly volatile
Short and Long Term Debt Total17.6 K16.8 K2.9 K
Slightly volatile
Short Term Debt10.7 K12.1 K13.2 K
Slightly volatile

Genenta Science Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization38.1 K40.1 K2.7 M
Slightly volatile
Interest Expense3.1 MM815.5 K
Slightly volatile
Selling General Administrative3.7 M5.7 M2.2 M
Slightly volatile
Other Operating Expenses8.9 M11.2 M6.5 M
Slightly volatile
Research Development5.2 M5.5 M4.3 M
Slightly volatile
Total Operating Expenses8.9 M11.2 M6.5 M
Slightly volatile
Cost Of Revenue50.2 K47.8 K12.5 K
Slightly volatile
Interest Income120.8 K93.3 K46 K
Slightly volatile
Selling And Marketing Expenses4.1 M4.6 MM
Slightly volatile

Genenta Science Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation736.4 K974.3 K733.7 K
Very volatile
Begin Period Cash FlowM4.2 M11.4 M
Pretty Stable
Depreciation53.8 K51.2 K13.2 K
Slightly volatile
Other Non Cash Items46.4 K72.6 K24.5 K
Slightly volatile
Capital Expenditures3.8 KK17.2 K
Slightly volatile
End Period Cash Flow3.9 M4.1 M17.7 M
Slightly volatile
Change To Netincome782.9 K935.1 K763.5 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio6.947.068.0416
Slightly volatile
Book Value Per Share1.380.791.121
Pretty Stable
Invested Capital23.7 M26.7 M29.1 M
Slightly volatile
Average Payables546.4 K352.4 K545.2 K
Pretty Stable
Capex To Depreciation0.110.127.514
Slightly volatile
PB Ratio6.947.068.0416
Slightly volatile
Inventory Turnover0.06310.04790.0592
Slightly volatile
Days Of Inventory On Hand5.3 K7.9 K6.3 K
Slightly volatile
Payables Turnover0.130.1410.0358
Slightly volatile
Average Inventory62.6 K65.1 K59.2 K
Slightly volatile
Cash Per Share1.350.81.1484
Very volatile
Days Payables Outstanding2.8 KK79.8 K
Slightly volatile
Income Quality0.720.630.6849
Slightly volatile
Tangible Asset Value24.9 M28 M30.6 M
Slightly volatile
Intangibles To Total Assets0.00560.00530.0011
Slightly volatile
Net Debt To EBITDA0.510.542.443
Slightly volatile
Current Ratio15.257.9310.6437
Slightly volatile
Tangible Book Value Per Share1.380.781.12
Pretty Stable
Shareholders Equity Per Share1.380.791.121
Pretty Stable
Debt To Equity9.0E-40.00110.0011
Slightly volatile
Capex Per Share3.0E-43.0E-40.001
Slightly volatile
Graham Net Net1.280.721.0393
Pretty Stable
Average Receivables1.3 M1.6 M1.5 M
Pretty Stable
Interest Debt Per Share5.0E-47.0E-46.0E-4
Slightly volatile
Debt To Assets8.0E-49.0E-40.001
Slightly volatile
Operating Cycle5.3 K7.9 K6.3 K
Slightly volatile
Price Book Value Ratio6.947.068.0416
Slightly volatile
Days Of Payables Outstanding2.8 KK79.8 K
Slightly volatile
Ebt Per Ebit1.031.050.9804
Pretty Stable
Company Equity Multiplier0.891.071.1073
Slightly volatile
Total Debt To Capitalization9.0E-40.00110.0011
Slightly volatile
Debt Equity Ratio9.0E-40.00110.0011
Slightly volatile
Quick Ratio15.247.9310.6733
Slightly volatile
Net Income Per E B T0.80.90.9843
Slightly volatile
Cash Ratio2.382.518.4294
Pretty Stable
Days Of Inventory Outstanding5.3 K7.9 K6.3 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0173
Slightly volatile
Price To Book Ratio6.947.068.0416
Slightly volatile
Debt Ratio8.0E-49.0E-40.001
Slightly volatile
Price Fair Value6.947.068.0416
Slightly volatile

Genenta Science Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap140.9 M88.3 M152.8 M
Slightly volatile
Enterprise Value120.5 M83 M134.1 M
Slightly volatile

Genenta Fundamental Market Drivers

Genenta Upcoming Events

24th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
24th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Genenta Science Financial Statements

Genenta Science stakeholders use historical fundamental indicators, such as Genenta Science's revenue or net income, to determine how well the company is positioned to perform in the future. Although Genenta Science investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genenta Science's assets and liabilities are reflected in the revenues and expenses on Genenta Science's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genenta Science SpA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue47.8 K50.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Genenta Science SpA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genenta Science's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genenta Science Spa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genenta Science Spa Stock:
Check out the analysis of Genenta Science Correlation against competitors.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genenta Science. Market participants price Genenta higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Genenta Science assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.56)
Return On Assets
(0.27)
Return On Equity
(0.60)
The market value of Genenta Science SpA is measured differently than its book value, which is the value of Genenta that is recorded on the company's balance sheet. Investors also form their own opinion of Genenta Science's value that differs from its market value or its book value, called intrinsic value, which is Genenta Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genenta Science's market value can be influenced by many factors that don't directly affect Genenta Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genenta Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genenta Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Genenta Science's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.